참고문헌
- Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L. and Kirn, D. (2000) An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat. Med. 6, 1134-1139. https://doi.org/10.1038/80474
- Kim, J. H., Lee, Y. S., Kim, H., Huang, J. H., Yoon, A. R. and Yun, C. O. (2006) Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J. Natl. Cancer Inst. 98, 1482-1493. https://doi.org/10.1093/jnci/djj397
- Chen, L., Chen, D., Gong, M., Na, M., Li, L., Wu, H., Jiang, L., Qian, Y., Fang, G. and Xue, X. (2009) Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. Cancer Lett. 284, 141-148. https://doi.org/10.1016/j.canlet.2009.04.026
- Yoo, J. Y., Kim, J. H., Kim, J., Huang, J. H., Zhang, S. N., Kang, Y. A., Kim, H. and Yun, C. O. (2008) Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition. Gene Ther. 15, 635-651. https://doi.org/10.1038/gt.2008.3
- Zhao, L., Dong, A., Gu, J., Liu, Z., Zhang, Y., Zhang, W., Wang, Y., He, L., Qian, C., Qian, Q. and Liu, X. (2006) The anti-tumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Ther. 13, 1011-1022. https://doi.org/10.1038/sj.cgt.7700969
- Steinwaerder, D. S., Carlson, C. A., Otto, D. L., Li, Z. Y., Ni, S. and Lieber, A. (2001) Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector. Nat. Med. 7, 240-243. https://doi.org/10.1038/84696
- Chengalvala, M. V., Lubeck, M. D., Selling, B. J., Natuk, R. J., Hsu, K. H., Mason, B. B., Chanda, P. K., Bhat, R. A., Bhat, B. M., Mizutani, S. (1991) Adenovirus vectors for gene expression. Curr. Opin. Biotechnol. 2, 718-722. https://doi.org/10.1016/0958-1669(91)90041-3
- Alemany, R., Balague, C. and Curiel, D. T. (2000) Replicative adenoviruses for cancer therapy. Nat. Biotechnol. 18, 723-727. https://doi.org/10.1038/77283
- Green, N. K., Herbert, C. W., Hale, S. J., Hale, A. B., Mautner, V., Harkins, R., Hermiston, T., Ulbrich, K., Fisher, K. D. and Seymour, L. W. (2004) Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus. Gene Ther. 11, 1256-1263. https://doi.org/10.1038/sj.gt.3302295
- Choi, I. K., Lee, Y. S., Yoo, J. Y., Yoon, A. R., Kim, H., Kim, D. S., Seidler, D. G., Kim, J. H. and Yun, C. O. (2010) Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy. Gene Ther. 17, 190-201. https://doi.org/10.1038/gt.2009.142
- Gomes, E. M., Rodrigues, M. S., Phadke, A. P., Butcher, L. D., Starling, C., Chen, S., Chang, D., Hernandez-Alcoceba, R., Newman, J. T., Stone, M. J. and Tong, A. W. (2009) Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells. Clin. Cancer Res. 15, 1317-1325. https://doi.org/10.1158/1078-0432.CCR-08-1360
- Zhang, Y. A., Nemunaitis, J., Samuel, S. K., Chen, P., Shen, Y. and Tong, A. W. (2006) Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA. Cancer Res. 66, 9736-9743. https://doi.org/10.1158/0008-5472.CAN-06-1617
- Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., Randlev, B., Gillenwater, A. M., Bruso, P., Kaye, S. B., Hong, W. K. and Kirn, D. H. (2000) A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. 6, 879-885. https://doi.org/10.1038/78638
- Nemunaitis, J., Ganly, I., Khuri, F., Arseneau, J., Kuhn, J., McCarty, T., Landers, S., Maples, P., Romel, L., Randlev, B., Reid, T., Kaye, S. and Kirn, D. (2000) Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res. 60, 6359-6366.
- Kiang, A., Hartman, Z. C., Everett, R. S., Serra, D., Jiang, H., Frank, M. M. and Amalfitano, A. (2006) Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. Mol. Ther. 14, 588-598. https://doi.org/10.1016/j.ymthe.2006.03.024
- Singh, R. and Kostarelos, K. (2009) Designer adenoviruses for nanomedicine and nanodiagnostics. Trends. Biotechnol. 27, 220-229. https://doi.org/10.1016/j.tibtech.2009.01.003
- Li, F., Zhang, Z. P., Peng, J., Cui, Z. Q., Pang, D. W., Li, K., Wei, H. P., Zhou, Y. F., Wen, J. K. and Zhang, X. E. (2009) Imaging viral behavior in Mammalian cells with self-assembled capsid-quantum-dot hybrid particles. Small 5, 718-726. https://doi.org/10.1002/smll.200801303
- Thompson, D. H. (2008) Adenovirus in a synthetic membrane wrapper: an example of hybrid vigor? ACS Nano 2, 821-826. https://doi.org/10.1021/nn800279s
- Fisher, K. D. and Seymour, L. W. (2010) HPMA copolymers for masking and retargeting of therapeutic viruses. Adv. Drug. Deliv. Rev. 62, 240-245. https://doi.org/10.1016/j.addr.2009.12.003
- Pearce, O. M., Fisher, K. D., Humphries, J., Seymour, L. W., Smith, A. and Davis, B. G. (2005) Glycoviruses: chemical glycosylation retargets adenoviral gene transfer. Angew. Chem. Int. Ed. Engl. 44, 1057-1061. https://doi.org/10.1002/anie.200461832
- Lee, G. K., Maheshri, N., Kaspar, B. and Schaffer, D. V. (2005) PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotechnol. Bioeng. 92, 24-34. https://doi.org/10.1002/bit.20562
- Jung, Y., Park, H. J., Kim, P. H., Lee, J., Hyung, W., Yang, J., Ko, H., Sohn, J. H., Kim, J. H., Huh, Y. M., Yun, C. O. and Haam, S. (2007) Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells. J. Control Release 123, 164-171. https://doi.org/10.1016/j.jconrel.2007.08.002
- Hofherr, S. E., Shashkova, E. V., Weaver, E. A., Khare, R. and Barry, M. A. (2008) Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol. Ther. 16, 1276-1282. https://doi.org/10.1038/mt.2008.86
- Yao, X., Yoshioka, Y., Morishige, T., Eto, Y., Watanabe, H., Okada, Y., Mizuguchi, H., Mukai, Y., Okada, N. and Nakagawa, S. (2009) Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis. Gene Ther. 16, 1395-1404. https://doi.org/10.1038/gt.2009.95
- Chan, P., Kurisawa, M., Chung, J. E. and Yang, Y. Y. (2007) Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials 28, 540-549. https://doi.org/10.1016/j.biomaterials.2006.08.046
- Doronin, K., Shashkova, E. V., May, S. M., Hofherr, S. E. and Barry, M. A. (2009) Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Hum. Gene Ther. 20, 975-988. https://doi.org/10.1089/hum.2009.028
- Eto, Y., Gao, J. Q., Sekiguchi, F., Kurachi, S., Katayama, K., Maeda, M., Kawasaki, K., Mizuguchi, H., Hayakawa, T., Tsutsumi, Y., Mayumi, T. and Nakagawa, S. (2005) PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J. Gene Med. 7, 604-612. https://doi.org/10.1002/jgm.699
- Gao, J. Q., Eto, Y., Yoshioka, Y., Sekiguchi, F., Kurachi, S., Morishige, T., Yao, X., Watanabe, H., Asavatanabodee, R., Sakurai, F., Mizuguchi, H., Okada, Y., Mukai, Y., Tsutsumi, Y., Mayumi, T., Okada, N. and Nakagawa, S. (2007) Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration. J. Control Release 122, 102-110. https://doi.org/10.1016/j.jconrel.2007.06.010
- Gressner, A. M. and Pfeiffer, T. (1986) Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulphate synthesis in hepatocytes. J. Clin. Chem. Clin. Biochem. 24, 821-829.
- Shayakhmetov, D. M., Li, Z. Y., Ni, S. and Lieber, A. (2004) Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 78, 5368-5381. https://doi.org/10.1128/JVI.78.10.5368-5381.2004
- Barton, K. N., Stricker, H., Kolozsvary, A., Kohl, R., Heisey, G., Nagaraja, T. N., Zhu, G., Lu, M., Kim, J. H., Freytag, S. O. and Brown, S. L. (2006) Polyethylene glycol (molecular weight 400 DA) vehicle improves gene expression of adenovirus mediated gene therapy. J. Urol. 175, 1921-1925. https://doi.org/10.1016/S0022-5347(05)00918-3
- Fisher, K. D., Stallwood, Y., Green, N. K., Ulbrich, K., Mautner, V. and Seymour, L. W. (2001) Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther. 8, 341-348. https://doi.org/10.1038/sj.gt.3301389
- Green, N. K., Morrison, J., Hale, S., Briggs, S. S., Stevenson, M., Subr, V., Ulbrich, K., Chandler, L., Mautner, V., Seymour, L. W. and Fisher, K. D. (2008) Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer. J. Gene Med. 10, 280-289. https://doi.org/10.1002/jgm.1121
- Lanciotti, J., Song, A., Doukas, J., Sosnowski, B., Pierce, G., Gregory, R., Wadsworth, S. and O'Riordan, C. (2003) Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Mol. Ther. 8, 99-107. https://doi.org/10.1016/S1525-0016(03)00139-4
- Hofherr, S. E., Mok, H., Gushiken, F. C., Lopez, J. A. and Barry, M. A. (2007) Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Hum. Gene Ther. 18, 837-848. https://doi.org/10.1089/hum.2007.0051
- Ogawara, K., Rots, M. G., Kok, R. J., Moorlag, H. E., Van Loenen, A. M., Meijer, D. K., Haisma, H. J. and Molema, G. (2004) A nsovel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum. Gene Ther. 15, 433-443. https://doi.org/10.1089/10430340460745766
- Park, J. W., Mok, H. and Park, T. G. (2008) Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus. Biochem. Biophys. Res. Commun. 366, 769-774. https://doi.org/10.1016/j.bbrc.2007.12.045
- Bonsted, A., Engesaeter, B. O., Hogset, A., Maelandsmo, G. M., Prasmickaite, L., D'Oliveira, C., Hennink, W. E., van Steenis, J. H. and Berg, K. (2006) Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor. J. Gene Med. 8, 286-297. https://doi.org/10.1002/jgm.853
- Morrison, J., Briggs, S. S., Green, N., Fisher, K., Subr, V., Ulbrich, K., Kehoe, S. and Seymour, L. W. (2008) Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor. Mol. Ther. 16, 244-251. https://doi.org/10.1038/sj.mt.6300363
- Maeda, M., Kida, S., Hojo, K., Eto, Y., Gaob, J. Q., Kurachi, S., Sekiguchi, F., Mizuguchi, H., Hayakawa, T., Mayumi, T., Nakagawa, S. and Kawasaki, K. (2005) Design and synthesis of a peptide-PEG transporter tool for carrying adenovirus vector into cells. Bioorg. Med. Chem. Lett. 15, 621-624. https://doi.org/10.1016/j.bmcl.2004.11.055
- Oh, I. K., Mok, H. and Park, T. G. (2006) Folate immobilized and PEGylated adenovirus for retargeting to tumor cells. Bioconjug. Chem. 17, 721-727. https://doi.org/10.1021/bc060030c
- Park, Y., Kang, E., Kwon, O. J., Hwang, T., Park, H., Lee, J. M., Kim, J. H. and Yun, C. O. (2010) Ionically crosslinked Ad/chitosan nanocomplexes processed by electro-spinning for targeted cancer gene therapy. J. Control Release. S0168-3659(10)00475-X [pii] 10.1016/j.jconrel.2010.06.027.
- Mok, H., Park, J. W. and Park, T. G. (2008) Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. Bioconjug. Chem. 19, 797-801. https://doi.org/10.1021/bc700464m
- Park, J. W., Mok, H. and Park, T. G. (2010) Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction. J. Control Release 142, 238-244. https://doi.org/10.1016/j.jconrel.2009.11.001
- Sarkar, D., Lebedeva, I. V., Su, Z. Z., Park, E. S., Chatman, L., Vozhilla, N., Dent, P., Curiel, D. T. and Fisher, P. B. (2007) Eradication of therapy-resistant human prostate tumors using a cancer terminator virus. Cancer Res. 67, 5434-5442. https://doi.org/10.1158/0008-5472.CAN-07-0195
- Sarkar, D., Su, Z. Z. and Fisher, P. B. (2006) Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy. Cell Cycle. 5, 1531-1536. https://doi.org/10.4161/cc.5.14.3095
- Kim, P. H., Kim, T. I., Yockman, J. W., Kim, S. W. and Yun, C. O. (2010) The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials 31, 1865-1874. https://doi.org/10.1016/j.biomaterials.2009.11.043
- Cattaneo, R., Miest, T., Shashkova, E. V. and Barry, M. A. (2008) Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat. Rev. Microbiol. 6, 529-540. https://doi.org/10.1038/nrmicro1927
- Saini, V., Martyshkin, D. V., Mirov, S. B., Perez, A., Perkins, G., Ellisman, M. H., Towner, V. D., Wu, H., Pereboeva, L., Borovjagin, A., Curiel, D. T. and Everts, M. (2008) An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. Small 4, 262-269. https://doi.org/10.1002/smll.200700403
피인용 문헌
- Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus vol.41, 2015, https://doi.org/10.1016/j.biomaterials.2014.11.021
- Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers vol.158, pp.3, 2012, https://doi.org/10.1016/j.jconrel.2011.12.008
- Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials vol.33, pp.6, 2012, https://doi.org/10.1016/j.biomaterials.2011.11.020
- Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy vol.11, pp.13, 2016, https://doi.org/10.2217/nnm-2016-0060
- Aminoclay as a highly effective cationic vehicle for enhancing adenovirus-mediated gene transfer through nanobiohybrid complex formation vol.49, 2017, https://doi.org/10.1016/j.actbio.2016.11.045
- Gene delivery via the hybrid vector of recombinant adeno-associated virus and polyethylenimine vol.52, 2014, https://doi.org/10.1016/j.ejps.2013.10.009
- Utilizing adenovirus vectors for gene delivery in cancer vol.11, pp.3, 2014, https://doi.org/10.1517/17425247.2014.874414
- Polymer-Based Delivery of Glucagon-Like Peptide-1 for the Treatment of Diabetes vol.2012, 2012, https://doi.org/10.5402/2012/340632
- Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivo vol.9, pp.2, 2015, https://doi.org/10.3892/etm.2014.2086
- Enhanced anti-tumor efficacy and safety profile of tumor microenvironment-responsive oncolytic adenovirus nanocomplex by systemic administration vol.28, 2015, https://doi.org/10.1016/j.actbio.2015.09.014
- Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model vol.220, 2015, https://doi.org/10.1016/j.jconrel.2015.10.015
- Therapeutic efficacy of a systemically delivered oncolytic adenovirus – Biodegradable polymer complex vol.34, pp.19, 2013, https://doi.org/10.1016/j.biomaterials.2013.03.004
- Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA vol.32, pp.22, 2011, https://doi.org/10.1016/j.biomaterials.2011.03.084
- Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model vol.231, 2016, https://doi.org/10.1016/j.jconrel.2016.02.046
- Current advances in developing cationic lipid-based nanoparticles as a vehicle for improving adenoviral gene delivery vol.46, pp.4, 2016, https://doi.org/10.1007/s40005-016-0261-0
- Hybrid Nanomaterial Complexes for Advanced Phage-guided Gene Delivery vol.3, 2014, https://doi.org/10.1038/mtna.2014.37
- Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling vol.14, pp.9-10, 2012, https://doi.org/10.1002/jgm.2673